ODYY (Odyssey Health) Earnings Yield (Joel Greenblatt) %: -30.49% (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Odyssey Health Earnings Yield (Joel Greenblatt) %?

Odyssey Health ODYY +36.11% Earnings Yield (Joel Greenblatt) % is -30.49% as of Apr. 2026. The stock has 4 warning signs investors should review. Among 850 Medical Devices & Instruments companies, Odyssey Health ranks worse than 92.35% on this metric.

Odyssey Health's Enterprise Value for the quarter that ended in Apr. 2026 was $8.13 Mil. Odyssey Health's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 was $-2.48 Mil. Odyssey Health's Earnings Yield (Joel Greenblatt) for the quarter that ended in Apr. 2026 was -30.49%.

The historical rank and industry rank for Odyssey Health's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

ODYY' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -90.09   Med: 0   Max: 0
Current: -74.07

ODYY's Earnings Yield (Joel Greenblatt) % is ranked worse than
92.35% of 850 companies
in the Medical Devices & Instruments industry
Industry Median: 0.83 vs ODYY: -74.07

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Odyssey Health's Forward Rate of Return (Yacktman) % for the quarter that ended in Apr. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Odyssey Health  (OTCPK:ODYY) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


Odyssey Health Earnings Yield (Joel Greenblatt) % Related Terms


Odyssey Health Earnings Yield (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Odyssey Health's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Odyssey Health Earnings Yield (Joel Greenblatt) % Chart

Odyssey Health Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Earnings Yield (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.21 -46.95 -40.32 -5.63 -36.63

Odyssey Health Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -526.32 -36.63 -9.91 -44.64 -30.49

ODYY vs NUWE, RBOT, PFSA: Earnings Yield (Joel Greenblatt) % Comparison

For the Medical Devices subindustry, Odyssey Health's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Odyssey Health Earnings Yield (Joel Greenblatt) % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Odyssey Health's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Odyssey Health's Earnings Yield (Joel Greenblatt) % falls into.



Odyssey Health Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

Odyssey Healths Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Jul. 2025 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-1.49/4.073278
=-36.58 %

Odyssey Health's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.48 Mil.


What does a Earnings Yield (Joel Greenblatt) % of -30.49% mean?
Odyssey Health (ODYY) has a Earnings Yield (Joel Greenblatt) % of -30.49% as of Apr. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Odyssey Health and its competitors. According to the industry distribution chart, Odyssey Health ranks #785 out of 850 companies in the Medical Devices & Instruments industry, placing it in the top 92.4%.
Is Odyssey Health's Earnings Yield (Joel Greenblatt) % too high?
Odyssey Health's current Earnings Yield (Joel Greenblatt) % is -30.49%. Based on the distribution chart, Odyssey Health ranks #785 out of 850 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Odyssey Health's Earnings Yield (Joel Greenblatt) % compare to NUWE and RBOT?
According to the Medical Devices & Instruments industry distribution chart, Odyssey Health ranks #785 out of 850 companies for Earnings Yield (Joel Greenblatt) %. This places Odyssey Health in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 0.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median Earnings Yield (Joel Greenblatt) % among Medical Devices & Instruments companies is 0.83, based on 850 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Odyssey Health and its competitors. For the Medical Devices & Instruments industry, the median Earnings Yield (Joel Greenblatt) % is 0.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Odyssey Health's current Earnings Yield (Joel Greenblatt) % is -30.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Odyssey Health stock overvalued right now?
Odyssey Health (ODYY) has a current Earnings Yield (Joel Greenblatt) % of -30.49%. The current Earnings Yield (Joel Greenblatt) % is -30.49%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Odyssey Health (ODYY), the current Earnings Yield (Joel Greenblatt) % is -30.49% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Odyssey Health Business Description

Address 2300 West Sahara Avenue, Suite 800 - No. 4012, Las Vegas, NV, USA, 89102
Odyssey Health Inc is a developing medical and pharmaceutical technology that solves unmet clinical needs and has a substantial market opportunity. Its medical devices include CardioMap and Save-A-Life.